Literature DB >> 10193435

Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity.

D P D'Cruz1, G Keser, H Direskeneli, M A Khamashta, G R Hughes.   

Abstract

Heating sera is used to inactivate complement but may affect the binding characteristics of autoantibodies. We studied the effect of heating sera from patients with systemic vasculitides and SLE on antibody binding to cultured human umbilical vein endothelial cells. Sera from 32 patients with systemic vasculitides, eight with SLE and 10 healthy controls were studied for anti-endothelial cell antibodies (AECA) using an ELISA before and after heating sera to 56 degrees C for 30 min. The median (range) AECA binding index in the patient group increased from 20% (0-153%) to 71.5% (10-259%) (P < 0.0001). The AECA binding index in the control group also increased from 14% (0-52%) to 90% (42-154%) (P < 0.0001). The increased binding was unaffected by the addition of fresh complement or removal of immune complexes and the increased binding after heating persisted even after cooling to 4 degrees C. Specificity experiments showed that after heating, the binding specificity of sera was lost. Removal of immunoglobulin with Protein A abolished the increased binding seen after heating. Heating sera increases AECA binding in both patient and control sera. The mechanism is probably non-specific damage to the immunoglobulin molecule, and heating sera should thus be avoided.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193435      PMCID: PMC1905244          DOI: 10.1046/j.1365-2249.1999.00845.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction.

Authors:  G G Hunder; W P Arend; D A Bloch; L H Calabrese; A S Fauci; J F Fries; R Y Leavitt; J T Lie; R W Lightfoot; A T Masi
Journal:  Arthritis Rheum       Date:  1990-08

3.  Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture.

Authors:  E L Cançado; L S Vilas-Boas; C P Abrantes-Lemos; N F Novo; G Porta; L C Da Silva; A A Laudanna
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

4.  Rheumatic disease sera reactive with capillaries in the mouse kidney.

Authors:  E M Tan; C M Pearson
Journal:  Arthritis Rheum       Date:  1972 Jan-Feb

5.  Human antibodies to vascular endothelium.

Authors:  K J Lindqvist; C K Osterland
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

6.  Granulocyte-mediated injury to herpes simplex virus-infected human endothelium.

Authors:  M R Visser; H S Jacob; J L Goodman; J B McCarthy; L T Furcht; G M Vercellotti
Journal:  Lab Invest       Date:  1989-02       Impact factor: 5.662

7.  Heat inactivation of serum potentiates anti-cardiolipin antibody binding in ELISA.

Authors:  H M Cheng; Y F Ngeow; C K Sam
Journal:  J Immunol Methods       Date:  1989-11-30       Impact factor: 2.303

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  D B Cines; A P Lyss; M Reeber; M Bina; R J DeHoratius
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.

Authors:  D P D'Cruz; F A Houssiau; G Ramirez; E Baguley; J McCutcheon; J Vianna; H J Haga; G T Swana; M A Khamashta; J C Taylor
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

View more
  4 in total

Review 1.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

2.  Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity.

Authors:  F Yu; M-H Zhao; Y-K Zhang; Y Zhang; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

3.  Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.

Authors:  Ingrid M Zöller-Utz; Birgit Esslinger; Anja Schulze-Krebs; Walburga Dieterich
Journal:  J Clin Immunol       Date:  2009-11-27       Impact factor: 8.317

Review 4.  Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.

Authors:  Cristiano Alessandri; Michele Bombardieri; Guido Valesini
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.